[AOCNMB]

AOCNMB Symposium 1
Molecular imaging

2017年10月5日(木) 15:30 〜 17:00 第2会場 (303+304 会議センター3F)

Chair：蓑島聡（ユタ大学　放射線科）

+全てマイスケジュールに登録

[BS1-01] Imaging of Cell-Based Therapies

佐藤則子 (Molecular Imaging Program, National Cancer Institute, National Institutes of Health, USA)

[BS1-02] Development of PET probes and anti-cancer drugs targeting a cancer-specific amino acid transporter, LAT1

永森收志 (大阪大学大学院医学系研究科　生体システム薬理学)

[BS1-03] Novel PET probe to visualize AMPA receptors in living human brain

高橋琢哉 (横浜市立大学大学院・医学研究科　生理学)

[AOCNMB]

AOCNMB Symposium 2
Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

2017年10月6日(金) 13:30 〜 15:30 第1会場 (メインホール会議センター1F)

Chair：東達也（放射線医学総合研究所）、大野和子（京都医療科学大学　放射線技術学科）

+全てマイスケジュールに登録

[BS2-01] Impact of radiation emergencies on people - lessons learned from the Fukushima Daiichi Nuclear Power Plant Accident

神谷研二 (広島大学、福島県立医科大学)

[BS2-02] Low Dose Radiation Effects on Fetus and Children

島田義也 (量子科学技術研究開発機構)

[BS2-03] ¹³¹I Thyroid Dose Estimation from Food and Drink in the Early Phase after Fukushima Daiichi Nuclear Power Plant Accident

河合理城 (株式会社三菱総合研究所　原子力安全事業本部　廃炉推進グループ)

[BS2-04] Estimation of thyroid equivalent dose at 1-year-old children by inhalation based on body surface contamination levels after the Fukushima Daiichi nuclear power plant accident

大葉隆 (福島県立医科大学)

[BS2-05] Special comment

福永久典 (クイーンズ大学ベルファストがん細胞生物学研究センター)

[AOCNMB]

AOCNMB Symposium 3
Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

2017年10月7日(土) 08:00 〜 10:00 第2会場 (303+304 会議センター3F)

Chair：立石宇貴秀（東京医科歯科大学　放射線科）、栗原千絵子（放射線医学総合研究所）

+全てマイスケジュールに登録

[BS3-01] Global standardization and regulatory approval of imaging products, initiated by QIBA and the professional societies: introductory remarks

栗原千絵子 (放射線医学総合研究所)

[BS3-02] Quantitative Imaging Biomarker Alliance (QIBA): Overview and Emphasis on Nuclear Medicine Based Approaches

Richard L. Wahl (Washington University School of Medicine in St Louis, USA)

[BS3-03] PET drug manufacturing and imaging site qualification programs in Japan

脇厚生 (放射線医学総合研究所)

[BS3-04] Activity of Quantitative Imaging Biomarkers Alliance (QIBA®) for Asian Network of FDG PET/CT Standardization

立石宇貴秀 (東京医科歯科大学　放射線科)

[AOCNMB]

AOCNMB Symposium 4
How to write scientific articles

2017年10月7日(土) 10:00 〜 12:00 第2会場 (303+304 会議センター3F)

Chair：絹谷清剛（金沢大学　核医学）、S.Rasoul Zakavi（Mashhad University of Medical Science）

+全てマイスケジュールに登録

[BS4-01] How to prepare an original article

Seyed Rasoul Zakavi (Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran)

[BS4-02] How to find an appropriate journal for submission

Ramin Sadeghi (Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran)

[BS4-03] Authorship and ethics

絹谷清剛 (金沢大学医薬保健研究域医学系　核医学)

セッション一覧

AOCNMBプログラム » AOCNMB Symposia

AOCNMB Symposium 1
Molecular imaging

[BS1-01] Imaging of Cell-Based Therapies

[BS1-02] Development of PET probes and anti-cancer drugs targeting a cancer-specific amino acid transporter, LAT1

[BS1-03] Novel PET probe to visualize AMPA receptors in living human brain

AOCNMB Symposium 2
Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

[BS2-01] Impact of radiation emergencies on people - lessons learned from the Fukushima Daiichi Nuclear Power Plant Accident

[BS2-02] Low Dose Radiation Effects on Fetus and Children

[BS2-03] ¹³¹I Thyroid Dose Estimation from Food and Drink in the Early Phase after Fukushima Daiichi Nuclear Power Plant Accident

[BS2-04] Estimation of thyroid equivalent dose at 1-year-old children by inhalation based on body surface contamination levels after the Fukushima Daiichi nuclear power plant accident

[BS2-05] Special comment

AOCNMB Symposium 3
Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

[BS3-01] Global standardization and regulatory approval of imaging products, initiated by QIBA and the professional societies: introductory remarks

[BS3-02] Quantitative Imaging Biomarker Alliance (QIBA): Overview and Emphasis on Nuclear Medicine Based Approaches

[BS3-03] PET drug manufacturing and imaging site qualification programs in Japan

[BS3-04] Activity of Quantitative Imaging Biomarkers Alliance (QIBA®) for Asian Network of FDG PET/CT Standardization

AOCNMB Symposium 4
How to write scientific articles

[BS4-01] How to prepare an original article

[BS4-02] How to find an appropriate journal for submission

[BS4-03] Authorship and ethics

認証

セッション一覧

AOCNMBプログラム » AOCNMB Symposia

AOCNMB Symposium 1Molecular imaging

AOCNMB Symposium 2Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

AOCNMB Symposium 3Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

AOCNMB Symposium 4How to write scientific articles

認証

AOCNMB Symposium 1
Molecular imaging

AOCNMB Symposium 2
Fukushima 2011 --- What we learned from the Nuclear Power Plant Accident ?

AOCNMB Symposium 3
Global standardization and regulatory approval of imaging products, initiated by QIBA(Quantitative Imaging Biomarker Alliance) and the professional societies

AOCNMB Symposium 4
How to write scientific articles